Volume 23 (2024)
Volume 22 (2023)
Volume 21 (2022)
Volume 20 (2021)
Volume 19 (2020)
Volume 18 (2019)
Volume 17 (2018)
Volume 16 (2017)
Volume 15 (2016)
Volume 14 (2015)
Volume 13 (2014)
Volume 12 (2013)
Volume 11 (2012)
Volume 10 (2011)
Number of Articles: 10
Original Article
Adding erythropoietin to intravenous methylprednisolone in acute treatment of attacks of neuromyelitis optica spectrum disorders: A randomized controlled trial
Pages 201-205
Psychometric assessment of the Persian version of the patient determined disease steps scale in patients with multiple sclerosis and neuromyelitis optica spectrum disorder
Pages 206-210
The effectiveness of amantadine and dalfampridine in improving fatigue in patients with multiple sclerosis: A randomized, double-blind, clinical trial
Pages 211-216
Trend of incidence and mortality of brain and central nervous system cancer in Iran from 1990 to 2017: A global burden of disease-based study
Pages 217-223
The effect of levetiracetam on depression and anti-oxidant activity in patients with epilepsy
Pages 224-229
Assessment of COVID-19 vaccine attitude in people with multiple sclerosis, its correlation with demographic factors, and fear of coronavirus: A cross-sectional survey
Pages 230-235
Association between plasma PCSK9 levels and lipid profile in patients with Parkinson’s disease and comparison with healthy subjects
Pages 236-243
Review Article
Transient global amnesia after COVID-19: A systematic scoping review of case reports
Pages 244-250
Clinical Notes
Initial clinical presentation of multiple sclerosis with concurrent COVID-19 infection: Case report and literature review
Pages 251-255
Letter to the Editor
Limited access to health care in patients with atypical parkinsonism during COVID-19 era may lead to higher mortality
Pages 256-258